发明申请
US20090318329A2 METHODS FOR ASSESSING SUITABILITY OF CANCER PATIENTS FOR TREATMENT WITH HISTONE DEACETYLASE INHIBITORS
审中-公开
用于评估癌症患者用HISTONE脱乙酰壳多糖酶抑制剂治疗的适用性的方法
- 专利标题: METHODS FOR ASSESSING SUITABILITY OF CANCER PATIENTS FOR TREATMENT WITH HISTONE DEACETYLASE INHIBITORS
- 专利标题(中): 用于评估癌症患者用HISTONE脱乙酰壳多糖酶抑制剂治疗的适用性的方法
-
申请号: US11884105申请日: 2008-06-24
-
公开(公告)号: US20090318329A2公开(公告)日: 2009-12-24
- 发明人: Qiang Yu
- 申请人: Qiang Yu
- 申请人地址: SG Singapore 138668
- 专利权人: Agency for Science, Technology and Research
- 当前专利权人: Agency for Science, Technology and Research
- 当前专利权人地址: SG Singapore 138668
- 优先权: SG200501603-5 20050310
- 主分类号: A61K38/02
- IPC分类号: A61K38/02 ; G01N33/68 ; C12Q1/02 ; G01N33/53 ; A61P35/00 ; C12Q1/68 ; A61K31/164
摘要:
This invention is in the field of cancer therapy and provides the use of E2F1 activity for assessing suitability of a cancer patient for treatment with histone deacetylase inhibitors (HDACIs).